SNC80

[1]Moye LS, et al. Delta opioid receptor agonists are effective for multiple types of headache disorders. Neuropharmacology. 2019 Apr;148:77-86.|[2]Bilsky EJ, et al. SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther. 1995 Apr;273 (1) :359-66.|[3]Calderon SN, et al. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+) -4-[ (alpha R) -alpha- ((2S,5R) -4-allyl-2,5-dimethyl-1-piperazinyl) -3- methoxybenzyl]-N, N-diethylbenzamide (SNC 80) : a highly selective, nonpeptide delta opioid receptor agonist. J Med Chem. 1994 Jul 8;37 (14) :2125-8.|[4]Vicente-Sanchez A, et al. The delta opioid receptor tool box. Neuroscience. 2016 Dec 3;338:145-159.|[5]Dripps IJ, et al. Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80. Br J Pharmacol. 2018 Mar;175 (6) :891-901.|[6]Metcalf MD, et al. The δ opioid receptor agonist SNC80 selectively activates heteromeric μ-δ opioid receptors. ACS Chem Neurosci. 2012 Jul 18;3 (7) :505-9.